Jiangsu vcare pharmaceutical technology
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (26)
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Started: 12/26/2025
Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
Started: 3/17/2025
Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
Started: 12/30/2024
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Started: 9/6/2024
Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo
Started: 10/31/2025
Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis
Started: 4/28/2025
Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
Started: 7/20/2023
Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Started: 4/26/2023
The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel
Started: 8/30/2018
A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.
Started: 4/30/2026
Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis
Started: 11/11/2025
Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers
Started: 8/5/2025
The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers
Started: 5/26/2025
Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis
Started: 7/27/2023
A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects
Started: 9/18/2024
Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects
Started: 7/22/2024
A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.
Started: 6/12/2023
PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers
Started: 12/9/2021
Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects
Started: 10/20/2022
Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects
Started: 6/18/2022
Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects
Started: 11/18/2021
A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects
Started: 8/24/2021
The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man
Started: 11/11/2019
Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19
Started: 4/3/2019
Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function
Started: 4/30/2026
Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function
Started: 4/30/2026